These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

77 related articles for article (PubMed ID: 46276)

  • 1. Regression of feline sarcoma virus-induced sarcomas in dogs. II. Immunologic investigations.
    Slauson DO; Osburn BI; Shifrine M; Dungworth DL
    J Natl Cancer Inst; 1975 Feb; 54(2):371-7. PubMed ID: 46276
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Regression of feline sarcoma virus-induced sarcomas in dogs. I. Morphologic investigations.
    Slauson DO; Osburn BI; Shifrine M; Dungworth DL
    J Natl Cancer Inst; 1975 Feb; 54(2):361-70. PubMed ID: 1113321
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Oncogenic activity of feline fibrosarcoma virus in newborn pigs.
    Pearsn LD; Snyder SP; Aldrich CD
    Am J Vet Res; 1973 Mar; 34(3):405-9. PubMed ID: 4348004
    [No Abstract]   [Full Text] [Related]  

  • 4. Antibody production and interaction with lymphoid cells in relation to tumor immunity in the Moloney sarcoma virus system.
    Harada M; Pearson G; Redmon L; Winters E; Kasuga S
    J Immunol; 1975 Apr; 114(4):1318-22. PubMed ID: 1090675
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Cell-mediated immunity to leukemia virus- and tumor-associated antigens in mice.
    Herberman RB; Holden HT; Ting CC; Lavrin DL; Kirchner H
    Cancer Res; 1976 Feb; 36(2 pt 2):615-21. PubMed ID: 56223
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Protection of cats against progressive fibrosarcomas and persistent leukemia virus infection by vaccination with feline leukemia cells.
    Grant CK; de Noronha F; Tusch C; Michalek MT; McLane MF
    J Natl Cancer Inst; 1980 Dec; 65(6):1285-92. PubMed ID: 6253714
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Reversal of SV40 tumor-mediated suppression of spleen cell cytotoxicity by antibody.
    Prather SO; Lausch RN
    J Immunol; 1977 Jan; 118(1):203-10. PubMed ID: 187698
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Abrogation of resistance to feline oncornavirus disease by immunization with killed feline leukemia virus.
    Olsen RG; Hoover EA; Schaller JP; Mathes LE; Wolff LH
    Cancer Res; 1977 Jul; 37(7 Pt 1):2082-5. PubMed ID: 67886
    [TBL] [Abstract][Full Text] [Related]  

  • 9. In vitro activity of lymphocytes and serum of C3Hf-Bu mice during the growth of methylcholanthrene-induced tumor and its regression following local irradiation.
    Jurin M; Suit HD
    Cancer Res; 1974 Apr; 34(4):672-8. PubMed ID: 4814987
    [No Abstract]   [Full Text] [Related]  

  • 10. Experimental oncornavirus vaccines in the cat.
    Yohn DS; Olsen RG; Schaller JP; Hoover EA; Mathes LE; Heding L; Davis GW
    Cancer Res; 1976 Feb; 36(2 pt 2):646-51. PubMed ID: 943234
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Spontaneous feline fibrosarcomas: transmissibility and ultrastructure of associated virus-like particles.
    Snyder SP
    J Natl Cancer Inst; 1971 Nov; 47(5):1079-85. PubMed ID: 5123335
    [No Abstract]   [Full Text] [Related]  

  • 12. Immune response to leukemia virus and tumor-associated antigens in cats.
    Essex M; Sliski A; Hardy WD; Cotter SM
    Cancer Res; 1976 Feb; 36(2 pt 2):640-5. PubMed ID: 56224
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Some data concerning immune processes in concomitant tumor immunity experimental models. Comparative in vivo and in vitro investigations II. In vitro experiments.
    Donovan G; Popp I; Badea E; Bologa L
    Neoplasma; 1977; 24(3):303-10. PubMed ID: 895940
    [TBL] [Abstract][Full Text] [Related]  

  • 14. The SM strain of feline sarcoma virus. Biologic and antigenic characterization of virus.
    Sarma PS; Sharar AL; McDonough S
    Proc Soc Exp Biol Med; 1972 Sep; 140(4):1365-8. PubMed ID: 5057599
    [No Abstract]   [Full Text] [Related]  

  • 15. Blocking of cell-mediated immunity to Moloney murine sarcoma virus-transformed cells by lactate dehydrogenase virus-antibody complex.
    McDonald TL
    J Natl Cancer Inst; 1983 Mar; 70(3):493-7. PubMed ID: 6572738
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Spontaneous tumor regression: possible relationship to in vitro parameters of tumor immunity.
    Hellström KE; Hellström I
    Natl Cancer Inst Monogr; 1976 Nov; 44():131-4. PubMed ID: 193017
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Persistent viremia after regression of primary virus-induced feline fibrosarcomas.
    Aldrich CD; Pedersen NC
    Am J Vet Res; 1974 Nov; 35(11):1383-7. PubMed ID: 4372912
    [No Abstract]   [Full Text] [Related]  

  • 18. Feline sarcoma virus tumor induction in cats and dogs.
    Gardner MB; Arnstein P; Johnson E; Rongey RW; Charman HP; Huebner RJ
    J Am Vet Med Assoc; 1971 Mar; 158(6):Suppl 2:1046+. PubMed ID: 5103501
    [No Abstract]   [Full Text] [Related]  

  • 19. Role of adhesion molecules in the immune reaction to M-MSV-induced tumors.
    Rosato A; Bronte V; Mandruzzato S; Zambon A; Calderazzo F; Biasi G; Zanovello P; Collavo D
    Int J Cancer Suppl; 1992; 7():24-7. PubMed ID: 1385341
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Tumor immunity in vivo: evidence that immune destruction of tumor leaves "bystander" cells intact.
    Weissman IL
    J Natl Cancer Inst; 1973 Aug; 51(2):443-8. PubMed ID: 4765368
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 4.